Company Market Research Report: Kernel
Company Overview
- Name: Kernel
- Mission: To transform neuromedicine by improving the way we measure the brain, thereby accelerating treatment discovery and improving patient outcomes through precision biomarkers.
- Founded: 2016
- Founders: No specific founders listed in provided data.
- Key People:
- Ryan Field, Ph.D., CEO & CTO
- Katherine Perdue, Ph.D., VP of Applied Science & Clinical Research
- Julien Dubois, Ph.D., VP of Data Science
- Gabe Lerner, VP of Software Engineering
- Dakota Decker, VP of Hardware Engineering
- Headquarters: No information is available
- Number of Employees: No information is available
- Revenue: No information is available
- Known For: Developing the time-domain functional near-infrared spectroscopy hardware product, Kernel Flow, and innovative neuromeasurement technology focusing on precision neuromedicine.
Products
Kernel Flow
- Description: Kernel Flow is a multimodal functional brain measurement headset designed to provide a comprehensive picture of cortical brain activity by combining high-resolution hemodynamic and EEG signatures.
- Key Features:
- Data Rich: Offers detailed maps of brain activity key patterns.
- Easy-to-Use: Portable, setup time of less than 3 minutes, and accessible via user-friendly software.
- Proven Technology: Validated through multiple peer-reviewed publications.
Flow2
- Description: The second generation neuro measurement system that advances the capabilities of Kernel Flow.
- Key Features:
- Sampling rate of 3.7 Hz for fast whole-head hemodynamic imaging.
- Records to standardized file formats.
- Equipped with real-time SDK for custom visualization or neurofeedback development.
- Supports automated data quality reports.
DevKit
- Description: Experimental and customizable system for developers and researchers.
- Key Features:
- Modular design allows the attachment of individual modules.
- Maintains the same core technology as Flow2.
Services
- Neuro Measurement Solutions: Offers study design consulting, protocol development, data analysis, and quality control metrics.
- Data Management Software: Streamlines study visits, organizes data, minimizes errors, and standardizes procedures.
Recent Developments
- Recent Product Launches:
- Launch of Flow2 Neuroimaging Technology.
- Research and Studies:
- Launched Observational Studies using Flow2 for identifying biomarkers of depression treatment response (August 2023).
- Cognitive Decline Study using Flow2 technology (August 2023).
- New Features:
- No specific new features postulated for existing products beyond the technological advancements already described.
- New Partnerships:
- No information is available about new partnerships.
Recent Publications & Validation Studies
- TD-fNIRS for Brain Metrics: Reliability of brain metrics using Kernel technology affirmed in a variety of scientific publications.
- Studies on Substance Effects: Validations of biomarker capabilities with studies on psychoactive substances like ketamine and alcohol.
- Biomarkers in Development: Active participation in studies for depression and cognitive decline.
Kernel continues to lead in the non-invasive brain measurement industry by consistently enhancing its technology offerings and supporting extensive research opportunities for neuromedicine advancements.